These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Models of care for vesicoureteral reflux with and without an end point of reflux resolution: a computer cost analysis. Raju GA; Marks AJ; Benoit RM; Docimo SG J Urol; 2013 Jun; 189(6):2287-92. PubMed ID: 23270912 [No Abstract] [Full Text] [Related]
26. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817 [TBL] [Abstract][Full Text] [Related]
27. [Bacterial flora of the urinary tract and its drug sensitivity in children with vesico-ureteral reflux]. Sakson B; Wyrebska-Ruge J; Lobka P; Milewska H Pol Merkur Lekarski; 2000 Sep; 9 Suppl 1():41-3. PubMed ID: 11081344 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of urinary tract infection in the emergency department and outpatient settings. Takhar SS; Moran GJ Infect Dis Clin North Am; 2014 Mar; 28(1):33-48. PubMed ID: 24484573 [TBL] [Abstract][Full Text] [Related]
29. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections]. Hallgren H; Gustafsson I; Ripa T Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531 [No Abstract] [Full Text] [Related]
30. [Urinary infection and vesico-ureteral reflux: protocol of diagnosis, treatment and control]. Heras M; Loris C An Esp Pediatr; 1988 Sep; 29 Suppl 33():119-23. PubMed ID: 3074680 [No Abstract] [Full Text] [Related]
31. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Matsumoto T; Hamasuna R; Ishikawa K; Takahashi S; Yasuda M; Hayami H; Tanaka K; Kiyota H; Muratani T; Monden K; Arakawa S; Yamamoto S Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062 [TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and treatment of urinary tract infections in children on the basis of various recommendations]. Załęska-Ponganis J; Jackowska T Dev Period Med; 2014; 18(4):464-9. PubMed ID: 25874785 [TBL] [Abstract][Full Text] [Related]
36. [Comparison of drug therapy and surgery in primary vesico-uretero-renal reflux]. Monatsschr Kinderheilkd; 1981 Jun; 129(6):316-23. PubMed ID: 6114409 [No Abstract] [Full Text] [Related]
37. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920 [TBL] [Abstract][Full Text] [Related]
38. Bladder volume at onset of vesicoureteral reflux is an independent risk factor for breakthrough febrile urinary tract infection. Alexander SE; Arlen AM; Storm DW; Kieran K; Cooper CS J Urol; 2015 Apr; 193(4):1342-6. PubMed ID: 25305355 [TBL] [Abstract][Full Text] [Related]